Avid Bioservices Inc (CDMO)

[jakedogman1]

looks like there is a drug shortage from a halo product due to demand...

hyqvia...

https://www.ashp.org/Drug-Shortages/Current-Shortages/Drug-Shortage-Detail.aspx?id=515

https://www.takeda.com/siteassets/system/what-we-do/research-and-development-rd-in-takeda/our-pipeline/pipeline_en_q4.pdf

from cj daddy note from ASM in oct 18. Note that Takeda bought Shire in dec 18

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=145011633

..F/U 329005: “After the meeting, Lias came over to Horselover45 and me for a sidebar. I asked about Halozyme. He said: We are still producing for Halozyme. Their main customer Roche ordered a stockpile a while back because they were planning that we were going to use a newer, state-of-the-art, process which would take a while to get all the FDA testing, paperwork, and approvals. We are cautiously optimistic that Roche has worked through that stockpile. Halozyme is supposed to be communicating the latest forecast in a week or so. We are the sole supplier of that product to Roche. That is because we were the only ones who passed all the strict requirements that they had (that is a remarkable achievement). Now, we know that Halozyme has a few more customers for this product and we are presently producing for one of them, Shire. Others may also use us. He did not elaborate on other customers but he restated that they want Halozyme's business to be more like 5% and not 95% of our total.”